Aurinia Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) - On-Demand Transcript
Hello, everyone. This is Thomas Yip from H.C. Wainwright. For our next presentation, we have Mr. Peter Greenleaf. He is the CEO and Director of Aurinia Pharmaceuticals, a commercial stage company focused on delivering treatments for serious diseases with a high unmet need. Peter, very happy to have you with us at our conference. Please go ahead.
Thanks, Tom, and I want to thank everybody at H.C. Wainwright for having us at the conference today. Good afternoon to everyone who is joining us, and I hope the conference is going well for you.
I'm going to spend, I guess, about 20 minutes to walk you through who we are as a company. And if you're aware of who we are, to give you an update on the most recent events and what we've been up to as an organization. But before I do, let me point you to our forward-looking statements. And of course, all of our most recently filed filings with the SEC
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |